What Researchers Did
Researchers proposed an algorithm for medicodental care in patients treated with bisphosphonates, categorized by their treatment status regarding bisphosphonate-associated osteonecrosis.
What They Found
The guideline addresses the growing concern of osteochemonecrosis of the jaws (ONJ) in patients receiving bisphosphonates, noting that current treatments like surgical debridement and hyperbaric oxygen therapy have been unsuccessful. It proposes specific recommendations for the medicodental care of three patient groups: those about to start bisphosphonate therapy, those on bisphosphonates without ONJ, and those with existing ONJ.
What This Means for Canadian Patients
This guideline offers a structured approach for healthcare providers to manage the dental care of patients on bisphosphonates, aiming to prevent or address osteochemonecrosis of the jaws. Following these recommendations could help Canadian patients reduce their risk of this severe complication and ensure appropriate dental management while on bisphosphonate therapy.
Canadian Relevance
This study has no direct Canadian connection as it was not conducted in Canada, nor does it specifically address Canadian healthcare contexts or populations.
Study Limitations
This guideline proposes recommendations based on current understanding rather than presenting new empirical data or a definitively proven treatment strategy.